Amplitude Surgical (AMPLI.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:AMPLI - FR0012789667 - Common Stock

6.25 EUR

-0.05 (-0.79%)

Last: 10/9/2025, 7:00:00 PM

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to AMPLI. AMPLI was compared to 63 industry peers in the Health Care Equipment & Supplies industry. While AMPLI is still in line with the averages on profitability rating, there are concerns on its financial health. AMPLI does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year AMPLI was profitable.
In the past year AMPLI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: AMPLI reported negative net income in multiple years.
Each year in the past 5 years AMPLI had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 0.39%, AMPLI is doing worse than 65.08% of the companies in the same industry.
The Return On Equity of AMPLI (1.15%) is worse than 65.08% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.48%, AMPLI is doing worse than 63.49% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AMPLI is significantly below the industry average of 9.95%.
The last Return On Invested Capital (3.48%) for AMPLI is above the 3 year average (2.94%), which is a sign of increasing profitability.

		Industry Rank	Sector Rank
ROA	0.39%
ROE	1.15%
ROIC	3.48%

ROA(3y)4.54%

ROA(5y)0.64%

ROE(3y)11.48%

ROE(5y)-1.81%

ROIC(3y)2.94%

ROIC(5y)N/A

1.3 Margins

With a Profit Margin value of 1.00%, AMPLI is not doing good in the industry: 60.32% of the companies in the same industry are doing better.
AMPLI has a Operating Margin (10.22%) which is comparable to the rest of the industry.
AMPLI has a Gross Margin of 79.74%. This is amongst the best in the industry. AMPLI outperforms 93.65% of its industry peers.
AMPLI's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	10.22%
PM (TTM)	1%
GM	79.74%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.67%

GM growth 5Y9.09%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AMPLI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AMPLI has about the same amount of shares outstanding.
Compared to 5 years ago, AMPLI has more shares outstanding
Compared to 1 year ago, AMPLI has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.42, we must say that AMPLI is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.42, AMPLI is not doing good in the industry: 69.84% of the companies in the same industry are doing better.
AMPLI has a Debt/Equity ratio of 1.11. This is a high value indicating a heavy dependency on external financing.
AMPLI has a Debt to Equity ratio of 1.11. This is amonst the worse of the industry: AMPLI underperforms 84.13% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.11
Debt/FCF	N/A
Altman-Z	1.42

ROIC/WACC0.48

WACC7.32%

2.3 Liquidity

AMPLI has a Current Ratio of 1.91. This is a normal value and indicates that AMPLI is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.91, AMPLI is doing good in the industry, outperforming 61.90% of the companies in the same industry.
AMPLI has a Quick Ratio of 1.91. This is a bad value and indicates that AMPLI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.94, AMPLI perfoms like the industry average, outperforming 42.86% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.91
Quick Ratio	0.94

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for AMPLI have decreased strongly by -97.47% in the last year.
The Revenue has been growing slightly by 4.25% in the past year.
AMPLI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.67% yearly.

EPS 1Y (TTM)-97.47%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-245.95%

Revenue 1Y (TTM)4.25%

Revenue growth 3Y8.63%

Revenue growth 5Y0.67%

Sales Q2Q%4.99%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 312.50, the valuation of AMPLI can be described as expensive.
Based on the Price/Earnings ratio, AMPLI is valued a bit more expensive than 63.49% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.82, AMPLI is valued quite expensively.

		Industry Rank	Sector Rank
PE	312.5
Fwd PE	N/A

4.2 Price Multiples

AMPLI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AMPLI is cheaper than 60.32% of the companies in the same industry.